Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in glenmark pharmaceuticals

Hindustan Unilever Completes Acquisition Of VWash From Glenmark Pharma

HUL has acquired intellectual property rights including trademarks, design and know-how related to the VWash brand worldwide.

Read More

Sensex Closes 180 Points Up, Glenmark Pharma Jumps 27 Pc

Cipla's stock jumped by 2.9 per cent to Rs 655.80 per unit after it announced the launch of remdesivir under its brand name Cipremi.

Read More

Glenmark, Cipla Stocks Surge After Nod To Launch Drugs For Mild-to-moderate COVID-19 Infections

At the same time, Cipla's stock jumped by 4.3 per cent to Rs 664.45 per unit after it announced the launch of remdesivir under its brand name Cipremi.

Read More

Glenmark Pharmaceuticals Gets USFDA Nod For Fingolimod Capsules

Shares of Glenmark Pharmaceuticals were trading at Rs 411.20 a piece on BSE in morning trade, up 1.44 per cent from their previous close.

Read More

Glenmark To Conduct Clinical Trials On Favipiravir Anti-Viral Tablets For COVID-19 Patients

Glenmark is the first pharmaceutical company in India to be given approval by the regulator to start the trial on COVID-19 patients in India.

Read More

Glenmark Makes Its Second Breakthrough In Cancer Drug Discovery

It’s the second such anti-cancer drug lead discovered by the Mumbai-based Indian drug maker based on its proprietary BEAT platform

Read More